Renal denervation for treatment of uncontrolled hypertension in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea)
Reports detailing the response of hypertensive patients to renal denervation (RDN) in Asian patients are limited. We evaluated 6- and 12-month outcomes after RDN in an Asian population and compared outcomes to a primarily Caucasian population. The Global SYMPLICITY Registry (GSR) is a prospective, a...
Gespeichert in:
| Veröffentlicht in: | Journal of human hypertension 2016-05, Vol.30 (5), p.315-321 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 321 |
|---|---|
| container_issue | 5 |
| container_start_page | 315 |
| container_title | Journal of human hypertension |
| container_volume | 30 |
| creator | Kim, B-K Böhm, M Mahfoud, F Mancia, G Park, S Hong, M-K Kim, H-S Park, S-J Park, C G Seung, K B Gwon, H-C Choi, D-J Ahn, T H Kim, C J Kwon, H M Esler, M Jang, Y S |
| description | Reports detailing the response of hypertensive patients to renal denervation (RDN) in Asian patients are limited. We evaluated 6- and 12-month outcomes after RDN in an Asian population and compared outcomes to a primarily Caucasian population. The Global SYMPLICITY Registry (GSR) is a prospective, all-comer, worldwide registry that evaluates the safety and effectiveness of RDN and includes the Korean registry substudy (GSR Korea) and a Caucasian subset (GSR Caucasian). Given differences in baseline characteristics among GSR Korea (
n
=93) as compared with GSR Caucasian (
n
=169) patients, including lower baseline office systolic blood pressure (SBP), lower body mass index and differences in medications, propensity score adjustment was performed when comparing the change in SBP between subsets. The 6- and 12-month change in SBP in GSR Korea was −19.4±17.2 and −27.2±18.1 mm Hg, respectively (
P |
| doi_str_mv | 10.1038/jhh.2015.77 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1779891857</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A451941395</galeid><sourcerecordid>A451941395</sourcerecordid><originalsourceid>FETCH-LOGICAL-c480t-c70b0b779cbdd7a8a5e5878bb878b4e0282e30f4fc51ce952096a534f7c4ee853</originalsourceid><addsrcrecordid>eNp9klGLEzEQxxdRvHr65LsEhONEW5PdpMn6VspZixWlPR_uKWR3Z7tbsklNskI_y31Zs_aUnhwSmITMb_6TyUySvCR4QnAm3u-aZpJiwiacP0pGhPLpmLGUP05GOGd4nKcUnyXPvN9hPDjF0-QsnRLG8pyOkts1GKVRBQbcTxVaa1BtHQoOVOjABGRr1JvSmuCs1lCh5rAHF8D4AW0NUgbNfBvt3u57_VvhA3Lgex08qp3tUGgALbQtYprNzZdvq-V8eX2D1rBtfXCHQWNj-9CgzzYmRZeLzfp4fPM8eVIr7eHF3X6efP94dT3_NF59XSzns9W4pAKHcclxgQvO87KoKq6EYsAEF0UxGAo4FSlkuKZ1yUgJOUtxPlUsozUvKYBg2XlyedTdO_ujBx9k1_oStFYGbO8lidoiJ4LxiL7-B93Z3sUf9DKdUhwJSvH_qKglOJlm4oTaKg2yNbUNTpVDajmjjOSUZPnwuMkDVFwVdG3sC9RtvL8XcHES0IDSofFW90Nn_H3w7REsnfXeQS33ru2UO0iC5TBZMk6WHCZL8qHyV3c19UUH1V_2zyhF4N0R8NFltuBOin5A7xfUNtWW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1778716380</pqid></control><display><type>article</type><title>Renal denervation for treatment of uncontrolled hypertension in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea)</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Kim, B-K ; Böhm, M ; Mahfoud, F ; Mancia, G ; Park, S ; Hong, M-K ; Kim, H-S ; Park, S-J ; Park, C G ; Seung, K B ; Gwon, H-C ; Choi, D-J ; Ahn, T H ; Kim, C J ; Kwon, H M ; Esler, M ; Jang, Y S</creator><creatorcontrib>Kim, B-K ; Böhm, M ; Mahfoud, F ; Mancia, G ; Park, S ; Hong, M-K ; Kim, H-S ; Park, S-J ; Park, C G ; Seung, K B ; Gwon, H-C ; Choi, D-J ; Ahn, T H ; Kim, C J ; Kwon, H M ; Esler, M ; Jang, Y S</creatorcontrib><description>Reports detailing the response of hypertensive patients to renal denervation (RDN) in Asian patients are limited. We evaluated 6- and 12-month outcomes after RDN in an Asian population and compared outcomes to a primarily Caucasian population. The Global SYMPLICITY Registry (GSR) is a prospective, all-comer, worldwide registry that evaluates the safety and effectiveness of RDN and includes the Korean registry substudy (GSR Korea) and a Caucasian subset (GSR Caucasian). Given differences in baseline characteristics among GSR Korea (
n
=93) as compared with GSR Caucasian (
n
=169) patients, including lower baseline office systolic blood pressure (SBP), lower body mass index and differences in medications, propensity score adjustment was performed when comparing the change in SBP between subsets. The 6- and 12-month change in SBP in GSR Korea was −19.4±17.2 and −27.2±18.1 mm Hg, respectively (
P
<0.001 for both vs baseline). GSR Caucasian had a SBP change similar to GSR Korea at 6 months (−20.9±21.4 mm Hg, unadjusted
P
=0.547, adjusted
P
=0.998), whereas at 12 months the change was significantly less pronounced (−20.1±23.9 mm Hg, unadjusted
P
=0.004, adjusted
P
=0.002). There were no protocol-defined procedure-related adverse events and no chronic adverse events associated with the device in an Asian population. RDN provided a significant reduction in 6- and 12-month office SBP among Asian patients, with a favorable safety profile. The 12-month SBP reduction was larger than that observed in Caucasian patients.</description><identifier>ISSN: 0950-9240</identifier><identifier>EISSN: 1476-5527</identifier><identifier>DOI: 10.1038/jhh.2015.77</identifier><identifier>PMID: 26155994</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/699/75/243 ; Adult ; Adverse events ; Aged ; Antihypertensive Agents - therapeutic use ; Asian people ; Blood Pressure ; Body mass index ; Care and treatment ; Catheter Ablation - statistics & numerical data ; Denervation ; Denervation - statistics & numerical data ; Epidemiology ; Female ; Health Administration ; Humans ; Hypertension ; Hypertension - drug therapy ; Hypertension - surgery ; Male ; Medicine ; Medicine & Public Health ; Methods ; Middle Aged ; original-article ; Patient outcomes ; Patients ; Population ; Prospective Studies ; Public Health ; Radiofrequency ablation ; Registries ; Renal Artery - innervation ; Treatment Outcome ; White people</subject><ispartof>Journal of human hypertension, 2016-05, Vol.30 (5), p.315-321</ispartof><rights>Macmillan Publishers Limited 2016</rights><rights>COPYRIGHT 2016 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group May 2016</rights><rights>Macmillan Publishers Limited 2016.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c480t-c70b0b779cbdd7a8a5e5878bb878b4e0282e30f4fc51ce952096a534f7c4ee853</citedby><cites>FETCH-LOGICAL-c480t-c70b0b779cbdd7a8a5e5878bb878b4e0282e30f4fc51ce952096a534f7c4ee853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/jhh.2015.77$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/jhh.2015.77$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26155994$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, B-K</creatorcontrib><creatorcontrib>Böhm, M</creatorcontrib><creatorcontrib>Mahfoud, F</creatorcontrib><creatorcontrib>Mancia, G</creatorcontrib><creatorcontrib>Park, S</creatorcontrib><creatorcontrib>Hong, M-K</creatorcontrib><creatorcontrib>Kim, H-S</creatorcontrib><creatorcontrib>Park, S-J</creatorcontrib><creatorcontrib>Park, C G</creatorcontrib><creatorcontrib>Seung, K B</creatorcontrib><creatorcontrib>Gwon, H-C</creatorcontrib><creatorcontrib>Choi, D-J</creatorcontrib><creatorcontrib>Ahn, T H</creatorcontrib><creatorcontrib>Kim, C J</creatorcontrib><creatorcontrib>Kwon, H M</creatorcontrib><creatorcontrib>Esler, M</creatorcontrib><creatorcontrib>Jang, Y S</creatorcontrib><title>Renal denervation for treatment of uncontrolled hypertension in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea)</title><title>Journal of human hypertension</title><addtitle>J Hum Hypertens</addtitle><addtitle>J Hum Hypertens</addtitle><description>Reports detailing the response of hypertensive patients to renal denervation (RDN) in Asian patients are limited. We evaluated 6- and 12-month outcomes after RDN in an Asian population and compared outcomes to a primarily Caucasian population. The Global SYMPLICITY Registry (GSR) is a prospective, all-comer, worldwide registry that evaluates the safety and effectiveness of RDN and includes the Korean registry substudy (GSR Korea) and a Caucasian subset (GSR Caucasian). Given differences in baseline characteristics among GSR Korea (
n
=93) as compared with GSR Caucasian (
n
=169) patients, including lower baseline office systolic blood pressure (SBP), lower body mass index and differences in medications, propensity score adjustment was performed when comparing the change in SBP between subsets. The 6- and 12-month change in SBP in GSR Korea was −19.4±17.2 and −27.2±18.1 mm Hg, respectively (
P
<0.001 for both vs baseline). GSR Caucasian had a SBP change similar to GSR Korea at 6 months (−20.9±21.4 mm Hg, unadjusted
P
=0.547, adjusted
P
=0.998), whereas at 12 months the change was significantly less pronounced (−20.1±23.9 mm Hg, unadjusted
P
=0.004, adjusted
P
=0.002). There were no protocol-defined procedure-related adverse events and no chronic adverse events associated with the device in an Asian population. RDN provided a significant reduction in 6- and 12-month office SBP among Asian patients, with a favorable safety profile. The 12-month SBP reduction was larger than that observed in Caucasian patients.</description><subject>692/699/75/243</subject><subject>Adult</subject><subject>Adverse events</subject><subject>Aged</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Asian people</subject><subject>Blood Pressure</subject><subject>Body mass index</subject><subject>Care and treatment</subject><subject>Catheter Ablation - statistics & numerical data</subject><subject>Denervation</subject><subject>Denervation - statistics & numerical data</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Health Administration</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - surgery</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Methods</subject><subject>Middle Aged</subject><subject>original-article</subject><subject>Patient outcomes</subject><subject>Patients</subject><subject>Population</subject><subject>Prospective Studies</subject><subject>Public Health</subject><subject>Radiofrequency ablation</subject><subject>Registries</subject><subject>Renal Artery - innervation</subject><subject>Treatment Outcome</subject><subject>White people</subject><issn>0950-9240</issn><issn>1476-5527</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9klGLEzEQxxdRvHr65LsEhONEW5PdpMn6VspZixWlPR_uKWR3Z7tbsklNskI_y31Zs_aUnhwSmITMb_6TyUySvCR4QnAm3u-aZpJiwiacP0pGhPLpmLGUP05GOGd4nKcUnyXPvN9hPDjF0-QsnRLG8pyOkts1GKVRBQbcTxVaa1BtHQoOVOjABGRr1JvSmuCs1lCh5rAHF8D4AW0NUgbNfBvt3u57_VvhA3Lgex08qp3tUGgALbQtYprNzZdvq-V8eX2D1rBtfXCHQWNj-9CgzzYmRZeLzfp4fPM8eVIr7eHF3X6efP94dT3_NF59XSzns9W4pAKHcclxgQvO87KoKq6EYsAEF0UxGAo4FSlkuKZ1yUgJOUtxPlUsozUvKYBg2XlyedTdO_ujBx9k1_oStFYGbO8lidoiJ4LxiL7-B93Z3sUf9DKdUhwJSvH_qKglOJlm4oTaKg2yNbUNTpVDajmjjOSUZPnwuMkDVFwVdG3sC9RtvL8XcHES0IDSofFW90Nn_H3w7REsnfXeQS33ru2UO0iC5TBZMk6WHCZL8qHyV3c19UUH1V_2zyhF4N0R8NFltuBOin5A7xfUNtWW</recordid><startdate>20160501</startdate><enddate>20160501</enddate><creator>Kim, B-K</creator><creator>Böhm, M</creator><creator>Mahfoud, F</creator><creator>Mancia, G</creator><creator>Park, S</creator><creator>Hong, M-K</creator><creator>Kim, H-S</creator><creator>Park, S-J</creator><creator>Park, C G</creator><creator>Seung, K B</creator><creator>Gwon, H-C</creator><creator>Choi, D-J</creator><creator>Ahn, T H</creator><creator>Kim, C J</creator><creator>Kwon, H M</creator><creator>Esler, M</creator><creator>Jang, Y S</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20160501</creationdate><title>Renal denervation for treatment of uncontrolled hypertension in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea)</title><author>Kim, B-K ; Böhm, M ; Mahfoud, F ; Mancia, G ; Park, S ; Hong, M-K ; Kim, H-S ; Park, S-J ; Park, C G ; Seung, K B ; Gwon, H-C ; Choi, D-J ; Ahn, T H ; Kim, C J ; Kwon, H M ; Esler, M ; Jang, Y S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c480t-c70b0b779cbdd7a8a5e5878bb878b4e0282e30f4fc51ce952096a534f7c4ee853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>692/699/75/243</topic><topic>Adult</topic><topic>Adverse events</topic><topic>Aged</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Asian people</topic><topic>Blood Pressure</topic><topic>Body mass index</topic><topic>Care and treatment</topic><topic>Catheter Ablation - statistics & numerical data</topic><topic>Denervation</topic><topic>Denervation - statistics & numerical data</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Health Administration</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - surgery</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Methods</topic><topic>Middle Aged</topic><topic>original-article</topic><topic>Patient outcomes</topic><topic>Patients</topic><topic>Population</topic><topic>Prospective Studies</topic><topic>Public Health</topic><topic>Radiofrequency ablation</topic><topic>Registries</topic><topic>Renal Artery - innervation</topic><topic>Treatment Outcome</topic><topic>White people</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, B-K</creatorcontrib><creatorcontrib>Böhm, M</creatorcontrib><creatorcontrib>Mahfoud, F</creatorcontrib><creatorcontrib>Mancia, G</creatorcontrib><creatorcontrib>Park, S</creatorcontrib><creatorcontrib>Hong, M-K</creatorcontrib><creatorcontrib>Kim, H-S</creatorcontrib><creatorcontrib>Park, S-J</creatorcontrib><creatorcontrib>Park, C G</creatorcontrib><creatorcontrib>Seung, K B</creatorcontrib><creatorcontrib>Gwon, H-C</creatorcontrib><creatorcontrib>Choi, D-J</creatorcontrib><creatorcontrib>Ahn, T H</creatorcontrib><creatorcontrib>Kim, C J</creatorcontrib><creatorcontrib>Kwon, H M</creatorcontrib><creatorcontrib>Esler, M</creatorcontrib><creatorcontrib>Jang, Y S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of human hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, B-K</au><au>Böhm, M</au><au>Mahfoud, F</au><au>Mancia, G</au><au>Park, S</au><au>Hong, M-K</au><au>Kim, H-S</au><au>Park, S-J</au><au>Park, C G</au><au>Seung, K B</au><au>Gwon, H-C</au><au>Choi, D-J</au><au>Ahn, T H</au><au>Kim, C J</au><au>Kwon, H M</au><au>Esler, M</au><au>Jang, Y S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Renal denervation for treatment of uncontrolled hypertension in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea)</atitle><jtitle>Journal of human hypertension</jtitle><stitle>J Hum Hypertens</stitle><addtitle>J Hum Hypertens</addtitle><date>2016-05-01</date><risdate>2016</risdate><volume>30</volume><issue>5</issue><spage>315</spage><epage>321</epage><pages>315-321</pages><issn>0950-9240</issn><eissn>1476-5527</eissn><abstract>Reports detailing the response of hypertensive patients to renal denervation (RDN) in Asian patients are limited. We evaluated 6- and 12-month outcomes after RDN in an Asian population and compared outcomes to a primarily Caucasian population. The Global SYMPLICITY Registry (GSR) is a prospective, all-comer, worldwide registry that evaluates the safety and effectiveness of RDN and includes the Korean registry substudy (GSR Korea) and a Caucasian subset (GSR Caucasian). Given differences in baseline characteristics among GSR Korea (
n
=93) as compared with GSR Caucasian (
n
=169) patients, including lower baseline office systolic blood pressure (SBP), lower body mass index and differences in medications, propensity score adjustment was performed when comparing the change in SBP between subsets. The 6- and 12-month change in SBP in GSR Korea was −19.4±17.2 and −27.2±18.1 mm Hg, respectively (
P
<0.001 for both vs baseline). GSR Caucasian had a SBP change similar to GSR Korea at 6 months (−20.9±21.4 mm Hg, unadjusted
P
=0.547, adjusted
P
=0.998), whereas at 12 months the change was significantly less pronounced (−20.1±23.9 mm Hg, unadjusted
P
=0.004, adjusted
P
=0.002). There were no protocol-defined procedure-related adverse events and no chronic adverse events associated with the device in an Asian population. RDN provided a significant reduction in 6- and 12-month office SBP among Asian patients, with a favorable safety profile. The 12-month SBP reduction was larger than that observed in Caucasian patients.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>26155994</pmid><doi>10.1038/jhh.2015.77</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0950-9240 |
| ispartof | Journal of human hypertension, 2016-05, Vol.30 (5), p.315-321 |
| issn | 0950-9240 1476-5527 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1779891857 |
| source | MEDLINE; SpringerLink Journals |
| subjects | 692/699/75/243 Adult Adverse events Aged Antihypertensive Agents - therapeutic use Asian people Blood Pressure Body mass index Care and treatment Catheter Ablation - statistics & numerical data Denervation Denervation - statistics & numerical data Epidemiology Female Health Administration Humans Hypertension Hypertension - drug therapy Hypertension - surgery Male Medicine Medicine & Public Health Methods Middle Aged original-article Patient outcomes Patients Population Prospective Studies Public Health Radiofrequency ablation Registries Renal Artery - innervation Treatment Outcome White people |
| title | Renal denervation for treatment of uncontrolled hypertension in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T08%3A13%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Renal%20denervation%20for%20treatment%20of%20uncontrolled%20hypertension%20in%20an%20Asian%20population:%20results%20from%20the%20Global%20SYMPLICITY%20Registry%20in%20South%20Korea%20(GSR%20Korea)&rft.jtitle=Journal%20of%20human%20hypertension&rft.au=Kim,%20B-K&rft.date=2016-05-01&rft.volume=30&rft.issue=5&rft.spage=315&rft.epage=321&rft.pages=315-321&rft.issn=0950-9240&rft.eissn=1476-5527&rft_id=info:doi/10.1038/jhh.2015.77&rft_dat=%3Cgale_proqu%3EA451941395%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1778716380&rft_id=info:pmid/26155994&rft_galeid=A451941395&rfr_iscdi=true |